Cargando…

Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood–optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION)

Granulocyte colony-stimulating factor (G-CSF) was reported to have a neuroprotective effect in a rat model of anterior ischemic optic neuropathy (rAION model). However, the therapeutic window and anti-inflammatory effects of G-CSF in a rAION model have yet to be elucidated. Thus, this study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Yao-Tseng, Huang, Tzu-Lun, Huang, Sung-Ping, Chang, Chung-Hsing, Tsai, Rong-Kung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087822/
https://www.ncbi.nlm.nih.gov/pubmed/27538969
http://dx.doi.org/10.1242/dmm.025999
_version_ 1782463976780595200
author Wen, Yao-Tseng
Huang, Tzu-Lun
Huang, Sung-Ping
Chang, Chung-Hsing
Tsai, Rong-Kung
author_facet Wen, Yao-Tseng
Huang, Tzu-Lun
Huang, Sung-Ping
Chang, Chung-Hsing
Tsai, Rong-Kung
author_sort Wen, Yao-Tseng
collection PubMed
description Granulocyte colony-stimulating factor (G-CSF) was reported to have a neuroprotective effect in a rat model of anterior ischemic optic neuropathy (rAION model). However, the therapeutic window and anti-inflammatory effects of G-CSF in a rAION model have yet to be elucidated. Thus, this study aimed to determine the therapeutic window of G-CSF and investigate the mechanisms of G-CSF via regulation of optic nerve (ON) inflammation in a rAION model. Rats were treated with G-CSF on day 0, 1, 2 or 7 post-rAION induction for 5 consecutive days, and a control group were treated with phosphate-buffered saline (PBS). Visual function was assessed by flash visual evoked potentials at 4 weeks post-rAION induction. The survival rate and apoptosis of retinal ganglion cells were determined by FluoroGold labeling and TUNEL assay, respectively. ON inflammation was evaluated by staining of ED1 and Iba1, and ON vascular permeability was determined by Evans Blue extravasation. The type of macrophage polarization was evaluated using quantitative real-time PCR (qRT-PCR). The protein levels of TNF-α and IL-1β were analyzed by western blotting. A therapeutic window during which G-CSF could rescue visual function and retinal ganglion cell survival was demonstrated at day 0 and day 1 post-infarct. Macrophage infiltration was reduced by 3.1- and 1.6-fold by G-CSF treatment starting on day 0 and 1 post-rAION induction, respectively, compared with the PBS-treated group (P<0.05). This was compatible with 3.3- and 1.7-fold reductions in ON vascular permeability after G-CSF treatment compared with PBS treatment (P<0.05). Microglial activation was increased by 3.8- and 3.2-fold in the early (beginning treatment at day 0 or 1) G-CSF-treated group compared with the PBS-treated group (P<0.05). Immediate (within 30 mins of infarct) treatment with G-CSF also induced M2 microglia/macrophage activation. The cytokine levels were lower in the group that received immediate G-CSF treatment compared to those in the later G-CSF treatment group (P<0.05). Early treatment with G-CSF stabilized the blood–ON barrier to reduce macrophage infiltration and induced M2 microglia/macrophage polarization to decrease the expressions of pro-inflammatory cytokines in this rAION model.
format Online
Article
Text
id pubmed-5087822
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-50878222016-10-31 Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood–optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION) Wen, Yao-Tseng Huang, Tzu-Lun Huang, Sung-Ping Chang, Chung-Hsing Tsai, Rong-Kung Dis Model Mech Research Article Granulocyte colony-stimulating factor (G-CSF) was reported to have a neuroprotective effect in a rat model of anterior ischemic optic neuropathy (rAION model). However, the therapeutic window and anti-inflammatory effects of G-CSF in a rAION model have yet to be elucidated. Thus, this study aimed to determine the therapeutic window of G-CSF and investigate the mechanisms of G-CSF via regulation of optic nerve (ON) inflammation in a rAION model. Rats were treated with G-CSF on day 0, 1, 2 or 7 post-rAION induction for 5 consecutive days, and a control group were treated with phosphate-buffered saline (PBS). Visual function was assessed by flash visual evoked potentials at 4 weeks post-rAION induction. The survival rate and apoptosis of retinal ganglion cells were determined by FluoroGold labeling and TUNEL assay, respectively. ON inflammation was evaluated by staining of ED1 and Iba1, and ON vascular permeability was determined by Evans Blue extravasation. The type of macrophage polarization was evaluated using quantitative real-time PCR (qRT-PCR). The protein levels of TNF-α and IL-1β were analyzed by western blotting. A therapeutic window during which G-CSF could rescue visual function and retinal ganglion cell survival was demonstrated at day 0 and day 1 post-infarct. Macrophage infiltration was reduced by 3.1- and 1.6-fold by G-CSF treatment starting on day 0 and 1 post-rAION induction, respectively, compared with the PBS-treated group (P<0.05). This was compatible with 3.3- and 1.7-fold reductions in ON vascular permeability after G-CSF treatment compared with PBS treatment (P<0.05). Microglial activation was increased by 3.8- and 3.2-fold in the early (beginning treatment at day 0 or 1) G-CSF-treated group compared with the PBS-treated group (P<0.05). Immediate (within 30 mins of infarct) treatment with G-CSF also induced M2 microglia/macrophage activation. The cytokine levels were lower in the group that received immediate G-CSF treatment compared to those in the later G-CSF treatment group (P<0.05). Early treatment with G-CSF stabilized the blood–ON barrier to reduce macrophage infiltration and induced M2 microglia/macrophage polarization to decrease the expressions of pro-inflammatory cytokines in this rAION model. The Company of Biologists Ltd 2016-10-01 /pmc/articles/PMC5087822/ /pubmed/27538969 http://dx.doi.org/10.1242/dmm.025999 Text en © 2016. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Research Article
Wen, Yao-Tseng
Huang, Tzu-Lun
Huang, Sung-Ping
Chang, Chung-Hsing
Tsai, Rong-Kung
Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood–optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION)
title Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood–optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION)
title_full Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood–optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION)
title_fullStr Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood–optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION)
title_full_unstemmed Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood–optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION)
title_short Early applications of granulocyte colony-stimulating factor (G-CSF) can stabilize the blood–optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (rAION)
title_sort early applications of granulocyte colony-stimulating factor (g-csf) can stabilize the blood–optic-nerve barrier and ameliorate inflammation in a rat model of anterior ischemic optic neuropathy (raion)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087822/
https://www.ncbi.nlm.nih.gov/pubmed/27538969
http://dx.doi.org/10.1242/dmm.025999
work_keys_str_mv AT wenyaotseng earlyapplicationsofgranulocytecolonystimulatingfactorgcsfcanstabilizethebloodopticnervebarrierandameliorateinflammationinaratmodelofanteriorischemicopticneuropathyraion
AT huangtzulun earlyapplicationsofgranulocytecolonystimulatingfactorgcsfcanstabilizethebloodopticnervebarrierandameliorateinflammationinaratmodelofanteriorischemicopticneuropathyraion
AT huangsungping earlyapplicationsofgranulocytecolonystimulatingfactorgcsfcanstabilizethebloodopticnervebarrierandameliorateinflammationinaratmodelofanteriorischemicopticneuropathyraion
AT changchunghsing earlyapplicationsofgranulocytecolonystimulatingfactorgcsfcanstabilizethebloodopticnervebarrierandameliorateinflammationinaratmodelofanteriorischemicopticneuropathyraion
AT tsairongkung earlyapplicationsofgranulocytecolonystimulatingfactorgcsfcanstabilizethebloodopticnervebarrierandameliorateinflammationinaratmodelofanteriorischemicopticneuropathyraion